Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Blood|December 20, 2014
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitorsPeter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transportDoreen Braun, Theo D Kim, Philipp le Coutre, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHDGero Massenkeil, Marion Nagy, Philipp Le Coutre, et al.
Frontiers in Oncology|November 22, 2021
Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric CohortNadine Lackamp, Ina Wilkemeyer, Ivan Jelas, et al.
Case Reports in Hematology|December 6, 2014
Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantationChristian Oberender, Lorenz Kleeberg, Nicola Nienhues, et al.
British Journal of Haematology|December 24, 2005
Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemiaJörg Westermann, Antje Lessen, Claudia Schlimper, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
European Journal of Haematology|March 27, 2003
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatmentGökben Baskaynak, Karl-Anton Kreuzer, Michaela Schwarz, et al.
European Journal of Haematology|January 27, 2011
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplantsPhilipp G Hemmati, Theis H Terwey, Philipp le Coutre, et al.
European Journal of Haematology|October 22, 2013
Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remissionPhilipp G Hemmati, Anthea Schulze-Luckow, Theis H Terwey, et al.
Pageof 11